OpenAI's Sam Altman and Science VP Kevin Weil hype AI-assisted dog cancer story ignoring there's no proof the vaccine worked
OpenAI leaders promote unproven AI-assisted dog cancer treatment
OpenAI CEO Sam Altman and Science VP Kevin Weil have touted a story involving an AI-assisted mRNA vaccine for a dog with cancer, claiming it represents a future of personalized medicine. However, critics highlight that there is no evidence the vaccine worked, and the dog's improvement is likely attributable to an existing immunotherapy treatment. The narrative has sparked debate about the role of AI in medical advancements and the need for rigorous proof of efficacy.
Key Takeaways
- 1.
The treatment cost approximately $3,000 for genome sequencing alone.
- 2.
The dog was also receiving a PD-1 inhibitor, a known effective immunotherapy.
- 3.
Egan Peltan criticized the narrative as storytelling for AGI true believers.
Get your personalized feed
Trace groups the biggest stories, videos, and discussions into one feed so you can stay current without scanning ten tabs.
Try Trace free